Treatment of 3LL tumor-bearing mice with the COX-2 inhibitor sc-58125 led to complete blockade of ARG1 expression in the tumor and a statistically significant decrease in tumor volume (compared to untreated tumor baring animals), an effect that was not observed in immune-deficient mice. The gene discussed is ARG1; the disease is neoplasm.